These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2354485)

  • 21. The effect of cimetidine on plasma lipoproteins.
    Hansen CP; Gerdes LU; Linholt J; Faergeman O; Boesby S
    Dan Med Bull; 1990 Apr; 37(2):195-6. PubMed ID: 2344775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postheparin lipolytic activity and plasma lipoprotein response to omega-3 polyunsaturated fatty acids in patients with primary hypertriglyceridemia.
    Nozaki S; Garg A; Vega GL; Grundy SM
    Am J Clin Nutr; 1991 Mar; 53(3):638-42. PubMed ID: 2000816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein E2 transgenic rabbits. Modulation of the type III hyperlipoproteinemic phenotype by estrogen and occurrence of spontaneous atherosclerosis.
    Huang Y; Schwendner SW; Rall SC; Sanan DA; Mahley RW
    J Biol Chem; 1997 Sep; 272(36):22685-94. PubMed ID: 9312550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of metoprolol and pindolol monotherapy on plasma lipid- and lipoprotein-cholesterol levels (including the HDL subclasses) in mild hypertensive males and females.
    Szollár LG; Mészáros I; Tornóci L; Rischák K; Molnár M; Mányai S
    J Cardiovasc Pharmacol; 1990 Jun; 15(6):911-7. PubMed ID: 1694913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in the plasma lipoprotein distribution of apolipoproteins C-II, C-III1, C-III2 and apolipoprotein B after heparin-induced lipolysis.
    Nestel PJ; Huff MW; Billington T; Fidge NH
    Biochim Biophys Acta; 1982 Jul; 712(1):94-102. PubMed ID: 7115750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term effects of beta-adrenoceptor blocking drugs with and without cardioselectivity and intrinsic sympathomimetic activity on lipoprotein metabolism in hypertriglyceridaemic patients and in normal men.
    Durrington PN; Brownlee WC; Large DM
    Clin Sci (Lond); 1985 Dec; 69(6):713-9. PubMed ID: 2866062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of beta blockers on blood lipid profile.
    Lehtonen A
    Am Heart J; 1985 May; 109(5 Pt 2):1192-6. PubMed ID: 2859784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of pindolol and metoprolol on plasma lipids and lipoproteins.
    Pasotti C; Capra A; Fiorella G; Vibelli C; Chierichetti SM
    Br J Clin Pharmacol; 1982; 13(Suppl 2):435S-439S. PubMed ID: 7104157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the metabolic effects of long-term treatment with pindolol or atenolol by hypertensive patients.
    Lehtonen A
    Cardiovasc Drugs Ther; 1988 Jan; 1(5):549-51. PubMed ID: 3154682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoprotein lipids and apoproteins during beta-blocker administration: comparison of penbutolol and atenolol.
    Välimäki M; Maass L; Harno K; Nikkilä EA
    Eur J Clin Pharmacol; 1986; 30(1):17-20. PubMed ID: 3709628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of dichlorvos on the activity of lipoprotein lipase from adipose tissue, on plasma lipids and postheparin lipolytic plasma activity in rats.
    Kozlowska A; Sadurska B; Szymczyk T
    Arch Toxicol; 1988; 62(2-3):227-9. PubMed ID: 3196159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of beta-blockers on plasma lipids during antihypertensive therapy.
    Lehtonen A
    J Cardiovasc Pharmacol; 1985; 7 Suppl 2():S110-4. PubMed ID: 2409357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of omega-3 fish oils on lipid metabolism, glycemic control, and blood pressure in type II diabetic patients.
    Kasim SE; Stern B; Khilnani S; McLin P; Baciorowski S; Jen KL
    J Clin Endocrinol Metab; 1988 Jul; 67(1):1-5. PubMed ID: 3379125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of protein-reduced diet on plasma lipids, apolipoproteins and lipolytic activities in patients with chronic renal failure.
    Attman PO; Gustafson A; Alaupovic P; Wang CS
    Am J Nephrol; 1984; 4(2):92-8. PubMed ID: 6586074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoprotein abnormalities in survivors of cerebral infarction with a special reference to apolipoproteins and triglyceride-rich lipoproteins.
    Matsuda M; Miyahara T; Murai A; Fujimoto N; Kameyama M
    Atherosclerosis; 1987 Nov; 68(1-2):131-6. PubMed ID: 3689476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term effects of pindolol on serum lipoproteins in hypertensive patients.
    Gretzer I; Rössner S
    Acta Med Scand; 1986; 219(4):367-70. PubMed ID: 3716878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A rapid radioimmunoassay of human apolipoproteins C-II and C-III.
    Gustafson S; Ostlund-Lindqvist AM; Vessby B
    Scand J Clin Lab Invest; 1984 Jun; 44(4):291-7. PubMed ID: 6463561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of alpha- and selective beta-blockade for hypertension control on plasma lipoproteins, apoproteins, lipoprotein subclasses, and postprandial lipemia.
    Superko HR; Wood PD; Krauss RM
    Am J Med; 1989 Jan; 86(1B):26-31. PubMed ID: 2913769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum lipids and apolipoproteins in patients with essential hypertension.
    Catalano M; Aronica A; Carzaniga G; Seregni R; Libretti A
    Atherosclerosis; 1991 Mar; 87(1):17-22. PubMed ID: 1872922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement of the lipid profile during long-term administration of pindolol and hydrochlorothiazide in patients with hypertension.
    Samuel P; Chin B; Fenderson RW; Schoenfeld BH; Gonasun LM; Lieberman S
    Am J Cardiol; 1986 Feb; 57(5):24C-28C. PubMed ID: 3946247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.